about
Neurodegeneration in Alzheimer's disease: caspases and synaptic element interdependencecIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoformsInvolvement of caspase 8 and c-FLIPL in the proangiogenic effects of the tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)Ripped to deathElevated NF-kappaB responses and FLIP levels in leukemic but not normal lymphocytes: reduction by salicylate allows TNF-induced apoptosisOnto better TRAILs for cancer treatmentResearch Advances on Pathways of Nickel-Induced ApoptosisFLIP the Switch: Regulation of Apoptosis and Necroptosis by cFLIPDED or alive: assembly and regulation of the death effector domain complexesViral infection and the evolution of caspase 8-regulated apoptotic and necrotic death pathwaysRIPK-dependent necrosis and its regulation by caspases: a mystery in five actsMechanism of procaspase-8 activation by c-FLIPLFLIP and the death effector domain familyc-FLIP, a master anti-apoptotic regulatorDoxorubicin activates nuclear factor of activated T-lymphocytes and Fas ligand transcription: role of mitochondrial reactive oxygen species and calciumCatalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosisc-Flip overexpression affects satellite cell proliferation and promotes skeletal muscle agingCellular IAPs inhibit a cryptic CD95-induced cell death by limiting RIP1 kinase recruitmentUnnatural amino acids increase sensitivity and provide for the design of highly selective caspase substrates.Mechanism and specificity of the human paracaspase MALT1.The many roles of FAS receptor signaling in the immune systemCaspase functions in cell death and disease.Intra- and interdimeric caspase-8 self-cleavage controls strength and timing of CD95-induced apoptosis.The role of cellular FLICE inhibitory protein (c-FLIP) in the pathogenesis and treatment of cancer.Human caspases: activation, specificity, and regulationDrug-induced caspase 8 upregulation sensitises cisplatin-resistant ovarian carcinoma cells to rhTRAIL-induced apoptosis.A novel caspase 8 selective small molecule potentiates TRAIL-induced cell death.Targeting the Anti-Apoptotic Protein c-FLIP for Cancer Therapy.Key note lecture: toward a mechanistic taxonomy for cell death programs.The flip side of FLIPThe protein structures that shape caspase activity, specificity, activation and inhibition.Caspase-8 and c-FLIPL associate in lipid rafts with NF-kappaB adaptors during T cell activation.Cellular FLICE-like inhibitory protein (C-FLIP): a novel target for cancer therapy.Cathepsin D primes caspase-8 activation by multiple intra-chain proteolysis.Activity of Uncleaved Caspase-8 Controls Anti-bacterial Immune Defense and TLR-Induced Cytokine Production Independent of Cell DeathTargeting cellular FLICE-like inhibitory protein as a novel approach to the treatment of Hodgkin's lymphoma.Caspase-containing complexes in the regulation of cell death and inflammation.Altered of apoptotic markers of both extrinsic and intrinsic pathways induced by hepatitis C virus infection in peripheral blood mononuclear cellsHigh distribution of CD40 and TRAF2 in Th40 T cell rafts leads to preferential survival of this auto-aggressive population in autoimmunityBalance between short and long isoforms of cFLIP regulates Fas-mediated apoptosis in vivo
P2860
Q21202836-03B809DD-A0EE-4D3A-BFA1-F1705912E63CQ24311676-2AF25E0D-D6DA-4809-BD5B-54366CFFF295Q24321282-C8C4FF41-0AFA-4E23-A1AE-D51979808C71Q24632980-A3D79647-78DD-4173-8844-3AAEE6CACBD9Q24682686-E63B6F55-1BC6-49D6-8C0D-A7ECB8BE9296Q26768160-3E34958E-6324-4AC1-8875-A5B4078E8A40Q26772023-56E4F713-0E2D-4D44-B846-539D0FACAF8AQ26773368-292BF0B7-1162-4D62-B244-09FABAD6D1B7Q26796544-D9ABF521-297C-4F48-8381-5C37EB0F6521Q27010127-F8051406-F706-493D-A039-AC2C92553522Q27026600-F6538515-F4B0-464D-B65D-F4A4FF5BB230Q27655368-9A4F6324-0BB1-48A8-99E3-11BA4D9777C3Q28297969-E5A95AB4-6363-43DD-A5E1-C5D831A8E878Q28391119-A437C244-C311-4159-A622-E79A043AC659Q28579647-66AA8417-F129-4D5E-AE91-CA37C8FB4B40Q28584976-16021ED2-06A0-435B-8574-4E75A6E56BB5Q28587861-A36408C3-1128-4C14-90DF-A3B9452CBDA7Q33589801-71B01A79-228B-4A67-B3EE-EAD4316D0C1BQ34038412-7FDEEA4B-76E3-40DD-9609-EAAB2660471CQ34151837-49447B27-ADDD-4C1D-8A3F-D04E83C3F0B6Q34205697-D4024FA3-02F8-4DE7-8EE3-4755C099F04BQ34336335-2736C909-9CB0-4440-B8FC-70ABBB8D85E9Q34400187-7F3A9E4B-3E87-4BE2-8FB3-5CB821D09CCCQ34488806-1DF7F386-C505-4CB3-8979-CBC9EFB8E24CQ34608215-D2B55043-CD52-461B-829E-D29C29CFE5A4Q34806765-4415ABE6-B532-4461-A5B0-AEFFE4FF0976Q35591146-FE281979-EBC9-4E29-99B4-B0BD6E04B77FQ35762274-176F63CD-3607-48CB-A29E-940C064894EDQ35828412-1A277A83-4FE7-42B0-8B6C-FF8A72A535D1Q35866111-42554F83-E58E-40A3-A024-4BFE44DD50C4Q35902423-68EBCDC9-3C03-40C3-BD1C-885463981708Q35906438-3D08C73E-094A-4E45-8DF3-8CDFC6026E22Q35915103-7D883EA0-4975-4718-86EC-AFCA3A322E05Q36033218-86F96FF2-EA8B-4334-92B3-C8DA18CC90C2Q36162984-64982DCB-FED0-4E46-8A51-8A41581CCB7DQ36500552-7FC8BC3A-5A32-49D9-A46C-A8771EEC5F24Q36559701-207D94ED-0A99-4411-8A24-32982077AA04Q36561161-F0DDEE89-501C-4A13-8205-520567F3BD1DQ36572935-3B484BB9-C1DE-479B-B64D-065AD246D210Q36598979-24EC5E9E-8ABD-471E-9A1B-CA10C93BB0E7
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Activation of caspases-8 and -10 by FLIP
@nl
Activation of caspases-8 and -10 by FLIP(L).
@ast
Activation of caspases-8 and -10 by FLIP(L).
@en
type
label
Activation of caspases-8 and -10 by FLIP
@nl
Activation of caspases-8 and -10 by FLIP(L).
@ast
Activation of caspases-8 and -10 by FLIP(L).
@en
prefLabel
Activation of caspases-8 and -10 by FLIP
@nl
Activation of caspases-8 and -10 by FLIP(L).
@ast
Activation of caspases-8 and -10 by FLIP(L).
@en
P2093
P2860
P356
P1433
P1476
Activation of caspases-8 and -10 by FLIP(L).
@en
P2093
Cristina Deis
Daniel P Sutherlin
Guy S Salvesen
Jean-Bernard Denault
Kelly M Boatright
P2860
P304
P356
10.1042/BJ20040809
P407
P577
2004-09-01T00:00:00Z